HighCape Capital Acquisition LLC

1 deals · 0 closed · 0 liquidated · 1 in flight

HighCape Capital Acquisition LLC is the sponsor entity behind HighCape Capital Acquisition Corp. (Nasdaq: CAPA), a blank-check company that launched its initial public offering in 2020 with a strategic focus on the healthcare and life sciences sector. HighCape Capital, a New York-based investment firm with deep expertise in therapeutics, diagnostics, and medical technology, serves as the institutional force behind the vehicle. SpacDesk currently tracks one deal associated with the sponsor, with neither a completed transaction nor a liquidation recorded in its history. For full filing records, deal timelines, and sponsor-level analytics on HighCape Capital Acquisition LLC, sign up for complete data access at SpacDesk.

Hot Seat Score

—Insufficient history

Close rate

—

Median speed

—

Blended redemption

—

Total votes / extensions

0 / 0

Composite score combining historical close rate, median speed to deal close, and blended redemption discipline across all SPACs this sponsor has run. Higher score = institutional reputation worth retaining. Updates as new vote / closing data lands.

Win Rate (settled)

—

Total IPO Capital

$206.0M

Avg Extensions / Deal

0.0

Canonical

highcape capital acquisition

Promote Economics (1 SPAC with data)

Principals (3)

Kevin RakinChief Executive Officer and Chairman of the Board

David ColpmanDirector Nominee

Robert TaubDirector Nominee

SPACs sponsored

Symbol	Issuer	IPO	IPO Size	Status	Target	Outcome	Extensions
HCCR	HighCape Capital Acquisition Corp. II	—	$206.0M	Withdrawn	—	—	0